Novantrone and disease progression Patient Reports February 11, 2012

Novantrone Side Effects Report #4709015-7
Novantrone side effect was reported by a Consumer or non-health professional from UNITED STATES on June 23, 2005. Female patient, 53 years of age, was diagnosed with multiple sclerosis  and was treated with Novantrone. After drug was administered, patient experienced the following side effects: asthenia, difficulty in walking, disease progression, multiple sclerosis , ovarian cyst , paraesthesia, polyp. Novantrone dosage: 10 MG, 1 IN 3 MONTHS, INTRAVENOUS. During the same period patient was treated with AVONEX. Patient recovered.

Novantrone Side Effects Report #4689621-9
Novantrone side effect was reported by a Physician from on Dec 08, 2004. Female patient, 49 years of age, weighting 127.0 lb, was diagnosed with multiple sclerosis  and was treated with Novantrone. After drug was administered, patient experienced the following side effects: disease progression, neurotoxicity. Novantrone dosage: unknown. Patient recovered.

Novantrone Side Effects Report #5065368-4
Novantrone side effect was reported by a Consumer or non-health professional from UNITED STATES on July 17, 2006. Female patient, 63 years of age, weighting 150.6 lb, was diagnosed with chronic myeloid leukaemia and was treated with Novantrone. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood urea increased, bone marrow failure, coagulopathy, disease progression, febrile neutropenia. Novantrone dosage: 16 MG, 1 IN 1 DAYS, INTRAVENOUS. During the same period patient was treated with MYLOTARG, FLUDARABINE PHOSPHATE, GEMCITABINE, FLUCONAZOLE, HYDROMORPHONE HYDROCHLORIDE, LORAZEPAM, LEVOFLOXACIN, INSULIN. Patient was hospitalized. Patient died on 04/02/2003.

Novantrone Side Effects Report #4936721-1
Novantrone side effect was reported by a Consumer or non-health professional from ITALY on Feb 22, 2006. Female patient, 35 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Novantrone. After drug was administered, patient experienced the following side effects: chloroma, disease progression, leukaemia recurrent, mastoiditis. Novantrone dosage: unknown. During the same period patient was treated with ATRA, MERCAPTOPURINE. Patient was hospitalized. Patient recovered.


Novantrone Side Effects Report #4954555-9
Novantrone side effect was reported by a Consumer or non-health professional from ITALY on Mar 13, 2006. Female patient, 35 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Novantrone. After drug was administered, patient experienced the following side effects: chloroma, disease progression, leukaemia recurrent, malignant neoplasm progression. Novantrone dosage: unknown. During the same period patient was treated with ATRA, MERCAPTOPURINE. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5492824-7
Novantrone side effect was reported by a Consumer or non-health professional from JAPAN on Oct 10, 2007. Male patient, 58 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Novantrone. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anaemia, blood lactate dehydrogenase increased, blood uric acid decreased, condition aggravated, disease progression, febrile neutropenia, gastrointestinal haemorrhage, haematemesis. Novantrone dosage: unknown. During the same period patient was treated with MYLOTARG, ITRACONAZOLE, MAXIPIME. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5274754-9
Novantrone side effect was reported by a Health Professional from UNITED STATES on Mar 16, 2007. Male patient, 67 years of age, was diagnosed with acute myeloid leukaemia and was treated with Novantrone. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, cerebral haemorrhage, disease progression, international normalised ratio increased, subarachnoid haemorrhage, white blood cell count decreased. Novantrone dosage: unknown. During the same period patient was treated with ETOPOSIDE, CYTARABINE. Patient died on 01/10/2007.

Novantrone Side Effects Report #5421458-5
Novantrone side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 08, 2007. Female patient, 66 years of age, weighting 116.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Novantrone. After drug was administered, patient experienced the following side effects: biopsy bone marrow abnormal, cardiac arrest , disease progression, dyspnoea, ejection fraction decreased, electrolyte imbalance, electromechanical dissociation, febrile neutropenia, fluid overload. Novantrone dosage: unknown. During the same period patient was treated with ETOPOSIDE, ACYCLOVIR, ALLOPUINOL, CALCIUM CARBONATE, CEFEPIME, NYSTATIN, PROTONIX. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5233238-4
Novantrone side effect was reported by a Health Professional from UNITED STATES on Jan 29, 2007. Female patient, 53 years of age, weighting 184.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Novantrone. After drug was administered, patient experienced the following side effects: cardiac failure congestive, disease progression, transaminases increased. Novantrone dosage: unknown. During the same period patient was treated with ETOPOSIDE, CYTARABINE, PROAMATINE, FLORINEF, WELLBUTRIN, ZOFRAN, SINGULAIR. Patient was hospitalized. Patient died on 06/25/2006.


Novantrone Side Effects Report #5699182-3
Novantrone side effect was reported by a Health Professional from UNITED STATES on Mar 24, 2008. Male patient, 20 years of age, weighting 198.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Novantrone. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, asthenia, disease progression, febrile neutropenia. Novantrone dosage: 16.8 MG, 1 IN 1 DAYS, INTRAVENOUS. During the same period patient was treated with ETOPOSIDE, CYTARABINE, ACYCLOVIR, LORAZEPAM, LEVOFLOXACIN. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5453544-8
Novantrone side effect was reported by a Health Professional from FRANCE on Sept 05, 2007. Female patient, 22 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Novantrone. After drug was administered, patient experienced the following side effects: bone marrow failure, diarrhoea, disease progression, hepatorenal syndrome, hyperthermia, septic shock. Novantrone dosage: 12 MG/M2, 1 IN 1 DAYS, INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with DAUNORUBICIN, AMOXICILLIN, ACYCLOVIR, FLUCONAZOLE, PENTAMIDINE ISETHIONATE, LIORESAL, ALODONT, LUTENYL. Patient was hospitalized. Patient died on 07/17/2006.

Novantrone Side Effects Report #5408204-6
Novantrone side effect was reported by a Consumer or non-health professional from BELGIUM on July 30, 2007. Male patient, 74 years of age, was treated with Novantrone. After drug was administered, patient experienced the following side effects: disease progression, hepatitis toxic, pneumonitis, respiratory failure. Novantrone dosage: unknown. During the same period patient was treated with CYTARABINE, GEMTUZUMAB OZOGAMICIN, ETOPOSIDE, CEFTAZIDIME, CASPOFUNGIN ACETATE. Patient was hospitalized. Patient died.

Novantrone Side Effects Report #5144599-9
Novantrone side effect was reported by a Health Professional from JAPAN on Oct 23, 2006. Male patient, 63 years of age, was treated with Novantrone. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, disease progression, white blood cell count increased. Novantrone dosage: unknown. During the same period patient was treated with MYLOTARG, CYTARABINE, ETOPOSIDE, FAMOTIDINE, LEVOFLOXACIN, FLUCONAZOLE, HACHIAZULE. Patient was hospitalized. Patient died on 07/08/2006.

Novantrone Side Effects Report #4635266-6
Novantrone side effect was reported by a Consumer or non-health professional from on Mar 29, 2005. Male patient, 62 years of age, was diagnosed with acute myeloid leukaemia and was treated with Novantrone. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea exacerbated, fluid overload, hypovolaemia, infection , pneumonia , renal failure acute, respiratory distress. Novantrone dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN. Patient died on 12/29/2004.


Novantrone Side Effects Report #4780477-2
Novantrone side effect was reported by a Health Professional from UNITED STATES on Sept 12, 2005. Male patient, 62 years of age, was diagnosed with acute myeloid leukaemia and was treated with Novantrone. After drug was administered, patient experienced the following side effects: bilirubin conjugated increased, blood bilirubin increased, blood calcium decreased, disease progression, dyspnoea, fluid overload, hypovolaemia, infection , pco2 decreased. Novantrone dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, CYTARABINE, ETOPOSIDE. Patient died on 12/29/2004.

Novantrone Side Effects Report #5313509-3
Novantrone side effect was reported by a Consumer or non-health professional from JAPAN on Apr 12, 2007. Male patient, 56 years of age, was treated with Novantrone. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anaemia, blood alkaline phosphatase abnormal, disease progression, febrile neutropenia, gingival bleeding, hypersensitivity, hypoalbuminaemia, lymphocyte count decreased. Novantrone dosage: unknown. During the same period patient was treated with MYLOTARG, CYTARABINE, ENOCITABINE, KELFIPRIM, ITRACONAZOLE, ALLOPURINOL. Patient recovered.

Novantrone Side Effects Report #5567518-X
Novantrone side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 06, 2007. Male patient, 51 years of age, was treated with Novantrone. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood lactate dehydrogenase increased, blood pressure increased, disease progression, disseminated intravascular coagulation, febrile neutropenia, hepatic enzyme increased, hypokalaemia, oedema. Novantrone dosage: 7 MG/M2, 1 IN 1 DAYS, INTRAVENOUS. During the same period patient was treated with MYLOTARG, AMPHOTERICIN B, CYTARABINE, LEVOFLOXACIN, FLUCONAZOLE, CEFTRIAXONE, RABEPRAZOLE. Patient was hospitalized. Patient recovered.

Novantrone Side Effects Report #5283269-3
Novantrone side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 13, 2007. Male patient, 35 years of age, was treated with Novantrone. After drug was administered, patient experienced the following side effects: disease progression, sepsis , weight increased. Novantrone dosage: unknown. During the same period patient was treated with MYLOTARG, CYTARABINE, ETOPOSIDE, FLUCONAZOLE, ROXATIDINE ACETATE, REBAMIPIDE, ALLOPURINOL. Patient recovered.

Novantrone Side Effects Report #5708770-7
Novantrone side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 03, 2008. Male patient, 35 years of age, was treated with Novantrone. After drug was administered, patient experienced the following side effects: disease progression, sepsis , weight increased. Novantrone dosage: unknown. During the same period patient was treated with MYLOTARG, FLUCONAZOLE, ROXATIDINE ACETATE, REBAMIPIDE, ALLOPURINOL, BACILLUS SUBTILIS, CYTARABINE. Patient recovered.